Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater.
about
Management of ampullary neoplasms: A tailored approach between endoscopy and surgeryExpression of CD24, P-cadherin and S100A4 in tumors of the ampulla of VaterPancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinomaAmpullary adenocarcinoma - differentiation matters.Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.Clinicopathological Study of Carcinoma of the Ampulla of Vater with Special Reference to MUC1, MUC2 and MUC5AC ExpressionGeneration and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell linesCytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosisCurrent strategies in the therapeutic approach for adenocarcinoma of the ampulla of Vater.Imaging of malignancies of the biliary tract- an update.Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes.Prognosis of ampullary cancer based on immunohistochemical type and expression of osteopontinTumors of ampulla of Vater: A case series and review of chemotherapy optionsPerformance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinomaValidation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma.Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome.Differentiation markers in pancreatic head adenocarcinomas: MUC1 and MUC4 expression indicates poor prognosis in pancreatobiliary differentiated tumours.Potential usefulness of mucin immunohistochemical staining of preoperative pancreatic biopsy or juice cytology specimens in the determination of treatment strategies for intraductal papillary mucinous neoplasmA retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy.Differential expression of E-cadherin, β-catenin, and S100A4 in intestinal type and nonintestinal type ampulla of Vater cancers.Prognostic factors for long-term survival in patients with ampullary carcinoma: the results of a 15-year observation period after pancreaticoduodenectomy.Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma.Ampullary cancer--a separate clinical entity?Twenty-six cases of advanced ampullary adenocarcinoma treated with systemic chemotherapy.Cancer of the ampulla of vater: current evaluation and therapy.Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity.The Prognostic Impact of the Carcinoembryonic Antigen in Ampullary Cancer - A Retrospective Single Center Study.Molecular signatures of mRNAs and miRNAs as prognostic biomarkers in pancreatobiliary and intestinal types of periampullary adenocarcinomasAmpullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases.Expression of CD15 in normal and metaplastic Paneth cells of the digestive tractDifferential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.Phenotypic characterization and clinical outcome in ampullary adenocarcinoma.Immunophenotyping of ampullary carcinomata allows for stratification of treatment specific subgroups.Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications.Surgical outcomes and prognostic factors for ampulla of Vater cancer.Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?Significance of GLUT1 expression in adenocarcinoma and adenoma of the ampulla of Vater.Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma.Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer.
P2860
Q26799743-B8F866B4-F379-486E-A816-14C4ECBF4CCDQ28302252-C1FA996C-E1E0-41AF-97AD-BFE616ED83F4Q33343098-99579700-4E05-4505-B017-B7BC77A5F6CFQ33365424-1292CEBB-0745-44CC-95BD-92117E5F7E62Q33556032-2DEC115F-5B22-44CA-B8AF-E6986C8A9340Q33831908-4EDD6A9F-CC2F-459E-8C2E-2CCED4E9AD07Q34078502-50E2B66A-9A53-48B9-BCC4-813AD2638302Q34413756-75ADC132-CF99-4A4A-AEA7-CA50162B99B3Q35022349-6BEC3CD1-32FB-4AA0-A90B-66E5F91A7EF2Q35093239-A5AFA8CC-3DB6-4DFD-AC14-A7BBFE742D1FQ35197256-AEBFA380-86BA-4463-ADB2-33362F399EB2Q35540997-3A49A5B8-FE12-4875-95B0-25A142352207Q35854505-EC9010A9-B9C9-41BC-B005-D7762A17A67CQ36109481-5BFE990A-7A0D-4809-9E72-834303678164Q36286689-29C9AB97-6FCB-4D89-BE8C-BF12A8D1E340Q36919864-50DEF895-9A59-4ADB-97AC-2ABD61957835Q37187307-306148C7-E714-490F-A922-BBC0A22BB408Q37288415-E553724F-E1BE-48F6-BABC-9761A3C85E65Q37345196-3FC55C1F-7D75-4BCA-90C6-630895A893C8Q37564069-6A2331EA-99A2-4415-9892-516DE41CB23EQ37645489-737C7D2A-9038-468A-B548-A0BF16DE9FE1Q37722822-BF3BF911-35A8-4377-B41F-AFDE2AB01F10Q38181195-743050C5-D5E3-4678-AF65-D93BF66B976CQ38183813-7E5BA676-D063-4501-8AFC-DE465FC4A453Q38285097-B371B14C-BB04-469C-B333-5C7CC04420E3Q38662233-087314EB-798C-43A0-8759-C06BE004ACAFQ38709332-25BE9252-B097-4360-ACC3-FA0BA743C287Q39061625-2487E1CB-ACE8-4BC3-9D6F-F31F1592290DQ39430742-B8E18F63-05D9-465E-A1D9-88BFB36D3C03Q39589133-33558543-80AB-4275-BF10-BF2928F62289Q40614381-437F8BA5-3D59-4AEA-891B-7420D2DB354DQ40774298-A44083D6-3F49-47D4-B011-CF65463D5826Q41187076-77ED0A9E-9198-45C1-8BC7-D4D634386634Q43733849-B2D70A36-2825-461C-B6E4-B2B2299940BFQ44845483-75F8B26E-6FF5-466E-958B-4CA0FC017CA4Q45307308-50466E44-62C0-4E84-8792-39228916A930Q46715175-32000DE4-6A4A-4A89-BAFE-6B9E7E4368AEQ47124313-6E7C6544-5335-4A41-87B1-672DB4B364DEQ49588315-88B7485D-23E3-4D2F-97FB-1F1B27A43326Q50217905-013C7A78-8E1C-40DE-B17D-F2C11EC3CA0A
P2860
Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Different clinicopathologic fi ...... carcinoma of papilla of Vater.
@en
Different clinicopathologic fi ...... carcinoma of papilla of Vater.
@nl
type
label
Different clinicopathologic fi ...... carcinoma of papilla of Vater.
@en
Different clinicopathologic fi ...... carcinoma of papilla of Vater.
@nl
prefLabel
Different clinicopathologic fi ...... carcinoma of papilla of Vater.
@en
Different clinicopathologic fi ...... carcinoma of papilla of Vater.
@nl
P2093
P2860
P1476
Different clinicopathologic fi ...... carcinoma of papilla of Vater.
@en
P2093
N Futakawa
S Yamagata
P2860
P304
P356
10.1111/J.1349-7006.1994.TB02077.X
P577
1994-02-01T00:00:00Z